3
548 J . Org. Chem., Vol. 63, No. 11, 1998
Slade and Branchaud
to ensure that solid PhSCo(dmgH) py, which forms as a
2
internal standard). Without further isolation, crude 12 was
used directly for the next step. Following the procedure for
the synthesis and purification of 15, crude 12 (0.0510 g, 0.0648
product of the reaction, stays near the bottom of each tube as
a lightly stirred precipitate rather than as a vigorously stirred
cloudy suspension which will slow the rate of reaction.
2 2
mmol), m-CPBA (0.0139 g, 0.0805 mmol), dry CH Cl (5.0 mL),
2
-Decyl-3-(th iop h en yl)su ccin ic An h yd r id e (10). Fol-
and 0.2 M pH 7.4 phosphate buffer (5.0 mL) provided 17 in
1
lowing the general procedure for photolyses, a solution of decyl
cobaloxime 6 (0.1054 g, 0.207 mmol), PhSSPh (0.0476 g, 0.218
quantitative yield. H NMR: δ 4.47-4.72 (m, 4H), 5.91 (br s,
1H), 6.06 (dd, 1H, J ) 3.0, 10.1 Hz), 6.29 (t, 1H; J ) 10.1 Hz),
1
3
mmol), and maleic anhydride (0.4069 g, 4.15 mmol) in dry CH
CN (10.0 mL) in an 18 mL Pyrex test tube was photolyzed for
0 h. Removal of the volatiles (rotary evaporation) and silica
gel chromatography provided 10 as a yellowish waxy solid.
Further purification by sublimation of excess maleic anhydride
and PhSSPh in a coldfinger sublimation apparatus at room
temp under vacuum, providing pure 10 in 64% isolated yield.
3
-
6.63 (s, 1H), 7.29-8.22 (20H). C NMR: δ (contains some
overlapping peaks) 29.67, 62.40, 66.28, 69.47, 69.99, 71.21,
91.40, 128.37, 128.43, 128.47, 128.62, 128.69, 128.77, 129.75,
129.88, 129.93, 130.11, 132.97, 133.33, 133.47, 133.60, 133.79,
133.99, 163.77, 165.10, 165.27, 165.34, 165.99. LRMS: (EI)
m/z (rel intensity); 677 (5%, M + 1), 579, 307, 289, 219, 154
1
(100%), 137, 105, 77. HRMS: calcd for C38
677.1659, obsd 677.1640.
29
H O12 (M + 1)
1
H NMR: δ 0.88 (m, 3H), 1.27 (br s, 14H), 1.45 (m, 2H), 1.69-
1
(
.95 (m, 2H), 2.92-2.99 (m, 1H), 3.83 (d, 1H; J ) 6.0 Hz), 7.39
1-(Th iop h en yl)-2,3,4,6-tetr a -O-ben zoyl-D-m a n n op yr a -
n ose (19). The product mixture from a reaction to convert 8
to 12 (see preceding paragraph) was purified by silica gel
column chromatography using 1:1 hexanes:EtOAc to provide
19 in 40% isolated yield. 1H NMR: δ 4.53-4.69 (m, 2H), 4.99-
5.03 (br m, 1H), 5.79 (s, 1H), 5.87 (dd, 2H; J ) 3.1, 10.1 Hz),
5.98 (s, 1H), 6.15 (t, 1H; J ) 10.2 Hz), 7.11-7.58 (m, 16H),
1
3
m, 3H), 7.55 (m, 2H). C NMR: δ (contains some overlapping
peaks) 13.85, 14.24, 22.63, 25.84, 26.31, 29.06, 29.22, 29.48,
2
1
3
9.92, 30.20, 47.09, 50.22, 121.20, 129.40, 129.71, 130.02,
34.68, 135.32, 169.36, 170.97. HRMS: calcd for C20
48.1759, obsd 348.1764.
28 3
H O S
2
-(1-Acetoxy-3-m eth ylbu tyl)-3-(th ioph en yl)su ccin ic An -
1
3
h yd r id e (11). This compound was synthesized and purified
as described for 10; R-acetoxycobaloxime 7 (0.1053 g, 0.212
mmol), PhSSPh (0.0486 g, 0.226 mmol), and maleic anhydride
0.4179 g, 4.26 mmol) in CH
for 10 h at 15 °C to give 11 in 81% yield. After purification,
1 was obtained as a clear yellow liquid as a 6:4 mixture of
diastereomers. H NMR: δ (containing both isomers) 0.91-
.99 (m, 6H), 1.46 (m, 1H), 1.61 (m, 2H), 2.00 and 2.05 (2s,
H), 3.15 and 3.22 (2m, 1H), 3.97 and 4.18 (2d, 1H; J ) 4.5
and 5.1 Hz), 5.30 and 5.48 (2m, 1H), 7.43 (m, 3H), 7.55 (m,
7.86 (d, 2H; J ) 7.5 Hz), 8.01-8.06 (m, 6H).
C NMR: δ
(contains some overlapping peaks) 63.08, 67.14, 69.92, 70.44,
71.95, 85.98, 126.27, 128.07, 128.33, 128.38, 128.60, 128.90,
129.23, 129.43, 129.76, 129.82, 129.84, 132.08, 132.71, 133.03,
133.27, 133.51, 165.30, 165.43, 165.48, 166.09. LRMS: (magic
bullet + NaI) m/z (rel intensity); 711 (80%, M + Na), 579, 481,
(
3
CN (10.0 mL) were photolyzed
1
1
323, 177, 105 (100%). HRMS: calcd for C40
obsd 711.1610.
32 9
H O SNa 711.1665,
0
3
(2,3,4,6-Tetr a -O-ben zoyl-D-glu cop yr a n osyl)m a leic An -
h yd r id e (18). Following the procedure for the synthesis of
10, 13 was synthesized from 9 (0.1945 g, 0.205 mmol), PhSSPh
(0.0506 g, 0.232 mmol), maleic anhydride (0.4023 g, 4.10
1
3
2
H). C NMR: δ (for both isomers; contains some overlapping
peaks) 20.57, 20.68, 21.98, 22.32, 22.41, 22.54, 24.64, 24.74,
2
1
1
9.66, 40.03, 41.08, 45.84, 47.91, 51.15, 70.47, 70.84, 129.23,
29.84, 129.88, 130.30, 135.05, 135.16, 167.48, 168.55, 168.94,
69.05, 169.14, 170.28. LRMS: (EI) m/z (rel intensity); 336
mmol), and 10.0 mL of dry CH
3
CN to produce 13 in 46% yield
CH as an internal stan-
(determined by 1H NMR using Ph
3
dard). Following the procedure for the synthesis and purifica-
(
C
15%, M), 294 (100%), 276, 249, 165, 95, 43. HRMS: calcd for
S 336.1031, obsd 336.1035.
Decylm a leic An h yd r id e (15). A two-phase system of 10
0.0850 g, 0.244 mmol) and m-CPBA (0.0509 g, 0.295 mmol)
in 5.0 mL of CH Cl and 5.0 mL of 0.2 M pH 7.4 phosphate
tion of 15, crude 13 (0.1133 g, 0.144 mmol), m-CPBA (0.0299
g, 0.173 mmol), dry CH Cl (5.0 mL), and 0.2 M pH 7.4
2 2
phosphate buffer (5.0 mL) provided 18 in quantitative yield.
17
H
20
O
5
(
Characterization data is given for the major isomer, presumed
1
2
2
to be the R isomer. H NMR: δ 4.46 (dd, 1H; J ) 3.8, 12.2
buffer was stirred under nitrogen at 0 °C for 2.5 h. The
reaction was poured into a 100 mL separatory funnel, 5.0 mL
of cold phosphate buffer was added, and the product was
extracted with cold CH
were combined, washed successively with dilute cold Na
and cold phosphate buffer (1 × 25 mL each), dried over Na
SO
removal of residual solvent on a vacuum line, clear liquid
product 15 was obtained in 81% yield. H NMR: δ 0.88 (t,
3
6
1
3
Hz), 4.63-4.69 (m, 1H), 5.15 (d quart, 1H; J ) 3.3, 9.0, 12.2
Hz), 5.42 (t, 1H; J ) 3.8 Hz), 5.68 (m, 2H), 5.88 (t, 1H; J ) 4.2
1
3
Hz), 7.01 (d, 1H; J ) 1.5 Hz), 7.2-8.3 (m, 20H). C NMR: δ
(contains some overlapping peaks) 60.94, 66.07, 66.92, 67.52,
67.86, 124.32, 128.39, 128.52, 128.69, 128.80, 129.26, 129.70,
129.92wd1, 133.42, 133.60, 133.94, 134.01, 135.36, 148.41,
162.71, 163.16, 164.52, 164.99, 165.25, 166.20. LRMS: (EI)
m/z (rel intensity); 676 (5%, M), 579, 335, 310, 231, 122, 105
2
Cl
2
(3 × 10 mL). The organic layers
2
S
2
O
3
2
-
4
, filtered, and evaporated (rotary evaporator). After
1
(100%), 77, 51. HRMS: calcd for C38
676.1602.
28
H O12 676.1581, obsd
H), 1.26 (br m, 14H), 1.63 (m, 2H), 2.51 (t, 2H; J ) 7.2 Hz),
13
.58 (s, 1H). C NMR: δ (contains some overlapping peaks)
4.04, 22.62, 25.91, 26.90, 29.04, 29.09, 29.22, 29.35, 29.46,
1.82, 128.39, 153.80, 163.98, 165.84. LRMS: (FAB) m/z (rel
Bis(d im e t h ylglyoxim a t o)(p yr id in e )(1-m yr ist yl)co-
ba lt (20). Following the procedure for the synthesis of 6, 20
was synthesized from bromotetradecane (myristyl bromide;
intensity); 239 (M, 45%), 186, 151, 141, 137, 125 (100%), 112,
1.73 mL, 5.8 mmol), CoCl
dimethylglyoxime (2.714 g, 23.4 mmol), pyridine (2.8 mL, 34.6
mmol), NaOH (50% aq solution; 1.63 g, 20.4 mmol), NaBH
(0.519 g, 13.7 mmol), CH OH (175 mL), and THF (5 mL). After
2
hexahydrate (2.757 g, 11.6 mmol),
1
2
09. HRMS: calcd for C14
39.1652.
23 3
H O (M + 1) 239.1647, obsd
4
(
1-Acetoxy-3-m eth ylbu tyl)m a leic An h yd r id e (16). Fol-
3
lowing the procedure for the synthesis of 15, 16 was synthe-
sized from 11 (0.1416 g, 0.421 mmol) and m-CPBA (0.0890 g,
addition of the alkyl bromide, the reaction was stirred for 1 h
at 0 °C and at room temp for 7.5 h, monitoring the disappear-
ance of the alkyl bromide by TLC. Following the general
procedure for the isolation and purification of 6 provided 20
as an orange solid in 84% isolated yield after chromatography.
0
.516 mmol) in CH
buffer (10.0 mL) in quantitative yield. H NMR: δ 0.96 (s,
H), 0.98 (s, 3H), 1.68-1.80 (m, 3H), 2.15 (s, 3H), 5.72-5.77
2 2
Cl (10.0 mL) and 0.2 M pH 7.4 phosphate
1
3
1
3
1
(
4
(
1
m, 1H), 6.68 (s, 1H). C NMR: δ 20.58, 21.52, 22.97, 24.76,
1.91, 66.71, 135.33, 152.07, 162.77, 163.36, 169.64. LRMS:
FAB, magic bullet) m/z (rel intensity); 227 (M, 20%), 185, 167,
49, 134, 124, 118, 84, 72, 54, 42 (100%). HRMS: calcd for
H NMR: δ 0.894 (m, 5H), 1.17-1.24 (m, 22H), 1.62 (t, 2H; J
) 8.7 Hz), 2.17 (s, 12H), 7.30 (t, 2H), 7.70 (t, 1H), 8.58 (d, 2H),
1
3
18.24 (br. s, dmgH-O-H).
C NMR: δ (contains some
overlapping peaks) 11.92, 14.06, 22.66, 29.32, 29.44, 29.63,
29.67, 30.66, 30.72, 31.89, 125.04, 137.23, 148.93, 149.98.
LRMS: (FAB) m/z (rel intensity); 565 (10%, M), 487, 463, 290
C
11
H
15
O
5
(M + 1) 227.0919, obsd 227.0930.
(
2,3,4,6-Tetr a-O-ben zoyl-D-m an n opyr an osyl)m aleic An -
h yd r id e (17). Following the procedure for the synthesis and
purification of 10, 12 was synthesized from 8 (0.1439 g, 0.152
mmol), PhSSPh (0.0348 g, 0.159 mmol), maleic anhydride
(100%), 205, 155, 117, 43. HRMS: calcd for C27
565.3037, obsd 565.3017.
2-Meth yl-2-(th iop h en yl)-3-m yr istylsu ccin ic An h yd r id e
(21). Following the procedure for the synthesis and purifica-
tion of 10, 21 was synthesized from myristyl cobaloxime (20;
48 5 4
H N O Co
(
0.2973 g, 3.03 mmol), and 7.6 mL of dry CH
3
CN to produce
1
1
2 in 19% yield (determined by H NMR using Ph CH as an
3